Trading Update and Strategic Update

Oxford Metrics warns of FY26 losses, missing revenue and profit targets by a wide margin.

What the company is saying

Oxford Metrics plc (LSE:OMG) is issuing a trading and strategic update disclosing that FY26 revenue is now expected between £47.0m and £51.0m, with an Adjusted EBIT loss of -£0.5m to -£3.9m, both well below current market expectations of £56.2m revenue and £3.0m Adjusted EBIT profit. The company attributes this shortfall to weaker demand in Vicon’s core entertainment markets, constrained research funding, and project delays in its Industrial Vision and Metrology Systems (IVMS) division. Management is accelerating cost-saving and margin improvement initiatives, targeting £1.5m–£2.0m in annualised savings, with £1.5m expected to benefit FY27 after reinvestment. The update highlights imminent strategic moves, including a planned acquisition of move:ai to strengthen Vicon’s markerless and hybrid capture capabilities, and a new share buyback programme of up to £3m. The company also notes the recent Captive Devices acquisition, new product launches, and exclusive rights to a large human movement dataset as steps to support recurring revenue growth. Leadership changes are confirmed, with Stefan Lampa joining as Group and Vicon Chief Executive on 1 December 2026, and Gary Bullard returning to Non-Executive Chair.

What the data suggests

Disclosed figures show a sharp deterioration in operational performance, with FY26 revenue guidance cut to £47.0m–£51.0m and an Adjusted EBIT loss of up to -£3.9m, compared to market expectations of £56.2m revenue and £3.0m profit. The company’s explanation for the miss—market weakness, funding pressures, and project delays—is consistent with sector headwinds but does not offset the magnitude of the shortfall. FY27 Adjusted EBIT is guided at or above £3.5m, but with revenue still below the expected £52.5m, and these are forward-looking targets rather than realised results. Cost savings of £1.5m–£2.0m are targeted, with £1.5m expected to benefit FY27, but only £0.6m has been realised so far. Cash and fixed-term deposits stand at approximately £29.5m as of 30 September 2026, providing balance sheet strength. The buyback and acquisitions signal capital deployment, but the immediate financial impact of these moves is not quantified. The update is transparent about underperformance but leans heavily on future improvements and strategic repositioning.

Analysis

The announcement is candid about underperformance, with FY26 revenue and Adjusted EBIT both expected to fall well below market expectations, and the company projecting a loss rather than a profit. While the tone is generally negative, the narrative attempts to offset this with forward-looking claims about cost savings, margin improvement, new product launches, and imminent acquisitions. However, most of these benefits are projected for FY27 or later, with only partial evidence of realised progress (e.g., cost savings already communicated, cash balance, and the completed Captive Devices acquisition). The planned acquisition of move:ai and incremental investments in Vicon are highlighted as strategic positives, but their financial impact is not quantified and remains future-dated. The capital intensity flag is triggered by the combination of ongoing investments, acquisitions, and a share buyback, none of which are paired with immediate earnings improvement. The gap between the company's narrative and the evidence lies in the heavy reliance on future benefits and strategic repositioning to counteract current operational weakness.

Risk flags

• ●Oxford Metrics faces significant operational risk from ongoing weakness in Vicon’s entertainment markets and delayed IVMS projects, which have already led to a major revenue and profit miss for FY26. This exposes the company to further downside if market conditions do not improve or if project delays persist.
• ●The company’s cost-saving and margin improvement programme is only partially realised, with most benefits projected for FY27. If these initiatives fail to deliver the targeted £1.5m–£2.0m in annualised savings, profitability may not recover as forecast.
• ●Strategic execution risk is elevated due to the planned acquisition of move:ai and the integration of Captive Devices, both of which require successful technology integration and commercialisation to generate the anticipated recurring revenue streams. Failure to execute could leave the company with increased costs and no offsetting revenue.
• ●The reliance on forward-looking statements for FY27 EBIT and revenue targets, without binding contracts or quantified financial impact from new products and acquisitions, increases the risk that actual results may again fall short of expectations.
• ●The planned £3m share buyback, while signalling confidence and capital discipline, will reduce available cash and could limit flexibility if operational performance deteriorates further or if integration costs from acquisitions are higher than planned.

Bottom line

Oxford Metrics is warning investors of a substantial miss on both revenue and profit for FY26, with a projected Adjusted EBIT loss of up to -£3.9m and revenue falling as much as £9.2m short of market expectations. Management is responding with accelerated cost-cutting, a new buyback, and strategic acquisitions aimed at recurring revenue, but most benefits are delayed until FY27 or later. The company’s cash position is strong at £29.5m, but the immediate outlook is weak and heavily reliant on successful execution of new initiatives and market recovery. Investors should view the near-term as high risk, with the main upside dependent on the integration and commercial impact of move:ai, Captive Devices, and new product launches. The most important takeaway is that Oxford Metrics’ current operational weakness is only partially offset by future-oriented strategy, and tangible evidence of margin recovery or recurring revenue growth will be needed to restore confidence.

Announcement summary

(LSE:OMG) Oxford Metrics plc issued an unaudited trading and strategic update for the 15-month period ending 31 December 2026 (FY26), following a change in accounting reference date from 30 September to 31 December. The Group expects FY26 revenue to be between £47.0m and £51.0m and an Adjusted EBIT loss of -£0.5m to -£3.9m, both below current market expectations of £56.2m revenue and £3.0m Adjusted EBIT profit. The Board attributes this underperformance to changes in Vicon’s end markets, pressure on research funding, and delays to major projects in Industrial Vision and Metrology Systems (IVMS). The FY26 revenue range assumes no contribution from a delayed phase of a major contact lens inspection programme, now expected in Q1 2027. For FY27, Adjusted EBIT is expected to be at or above the current market expectation of £3.5m, with revenue below the current market expectation of £52.5m. The Group is accelerating cost savings and margin improvement actions ahead of the 2027 implementation plan, with total net annualised savings of £1.5m to £2.0m targeted, including £0.6m already communicated, and approximately £1.5m expected to benefit FY27 after planned reinvestment. Cash and fixed-term deposits at 30 September 2026 were approximately £29.5m. Oxford Metrics plans to launch a further share buyback programme of up to £3m, with details to be announced separately. The Group is directing incremental investment to Vicon’s opportunities in markerless and hybrid systems, robotics, and recurring software revenue. An imminent acquisition of move:ai is expected to complement Vicon’s business, providing immediate access to markerless applications and customer relationships, and technology integration opportunities. The acquisition of Captive Devices, announced on 1 September, adds facial capture to Vicon’s body-tracking capabilities. Vicon has launched Nexus Markerless for health and life sciences, available exclusively through recurring software subscriptions, and a new version of the Vero camera. The Group has secured market-exclusive rights to a substantial third-party dataset of human movement recordings. IVMS has developed three new offerings across optical inspection, medical equipment, and semiconductor-related applications, with initial pilot systems sold and further deployments expected on customer validation. Operational efficiency measures include integration of IVMS operations, removal of lower-margin products, and headcount reductions in July and August. The Group and Vicon Managing Director roles will be combined, with Stefan Lampa joining as Group and Vicon Chief Executive on 1 December 2026, and Gary Bullard returning to his role as Non-Executive Chair. IVMS will continue as a standalone division reporting to the new CEO. The Group is focused on improving margins and developing more recurring revenue for 2027.

Disagree with this article?